Safety Study of HemaMax™ (rHuIL-12) to Treat Acute Radiation Syndrome

计划入组 200 人 · 首次发布于 2015 年 1 月 21 日

Open-label Phase I Study for PEP or Treatment of HS-ARS PLX-R18 for the Post-Exposure Prevention (PEP) or Treatment of Hematopoietic Syndrome of Acute Radiation Syndrome (HS-ARS)

计划入组 27 人 · 首次发布于 2019 年 1 月 8 日

BIO 300 Oral Powder Safety and Pharmacokinetics

计划入组 34 人 · 首次发布于 2020 年 12 月 2 日

Acute radiation syndrome(Ceramedix)

radiation sensitizer

Severe acute respiratory syndrome vaccine (Sanofi)

RADIATION ONCOLOGY

United States

ALPORT SYNDROME FOUNDATION

United States

Radiation Oncology Department

United States

Tivic Health Secures BARDA Meeting to Advance Entolimod for Acute Radiation Syndrome

European Medicines Agency Recommends Approval of Partner Therapeutics' IMREPLYS for Acute Radiation Syndrome Treatment

Synedgen and BARDA Partner to Develop MIIST305 for Gastrointestinal Acute Radiation Syndrome